THE MEDACIST DIFFERENCE: One Mission, Deep Insights

“The only source of knowledge is experience.” – Albert Einstein

Since its inception in 1998, our goal at Medacist has never wavered or changed – ?to use the best data and analytics available to put an end to instances of drug diversion.?

Fast forward to the present day, our focus has only become stronger. Supported by 23 years of industry data, insights and analytics. our foundation and experience has only gotten stronger and our insights all the more accurate. This is something that cannot be replicated and is a chief differentiator in any form of data or analytical pursuit. Among those challenges, I’ve outlined several other critical considerations in my recent byline, “Drug Diversion is Complicated: 5 Data-Related Challenges to Overcome,” published in HIT Consultant. ??

Due to its complexity and life-threatening repercussions, drug diversion is a serious challenge for our nation’s healthcare providers. We’ve had some incredible guests on our RxRoundtable Podcast, including VP of Nursing and Chief Nursing Officer Barbara Jacobs of Anne Arundel Medical Center, who underscore the need for dedicated solutions to a problem that thrives in the shadows. So, don’t just take my word for it.

There are certain things that are ok to skimp on in life, such as cereal or cleaning supplies… Battling drug diversion, however, is not one of those items, and that is why we have one focus and mission at Medacist.

Don’t settle for a solution that delivers generic or halfway insights. A number of players in the space may tout their size and sophistication, but in actuality, lack the historical data or dedicated solutions to make the requisite impact. These competitive offerings, often labeled as “a-la-carte” solution, is not only disrespectful to the healthcare industry but demonstrate the lack of conviction to help make a difference against a growing opioid abuse epidemic.

If you are reading this and hold a position to decide which drug diversion solution your facilities employ, I strongly urge you to think hard about your current capabilities and how Medacist can help you improve. As the only U.S. patent for drug diversion, our solutions protect 67% of the U.S. patient population and over 3 million clinicians across 2000+ facilities nationwide.

?Thank you, and I look forward to showing you the Medacist difference. ?

?

?

?

?

?

?

?

?

?

?